Literature DB >> 9875726

Endothelin in perivascular nerves. An electron-immunocytochemical study of rat basilar artery.

A Loesch1, P Milner, G Burnstock.   

Abstract

The endothelium is recognized as a major source of endothelin in the vasculature. In this report we show for the first time that endothelin can be demonstrated with immunoelectronmicroscopy in perivascular nerves. About 36% of the axon profiles (varicosity/intervaricosity) examined in the rat basilar artery showed immunolabelling with a polyclonal antibody to endothelin-1. Endothelin-labelled axon varicosities were characterized by the presence of small spherical agranular vesicles (42 +/- 1 nm); some varicosities also contained large granular vesicles (92 +/- 5 nm) with labelled cores. Immunolabelling was mostly distributed in the axoplasm and in association with the membrane of synaptic vesicles (the lumen of the small agranular vesicles was immuno-negative). The presence of endothelin in perivascular nerves of the basilar artery suggests a neuronal as well as endothelial role in the physiological control of the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875726     DOI: 10.1097/00001756-199812010-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Endothelin-1 and endothelin receptors in the basilar artery of the capybara.

Authors:  Andrzej Loesch; Barbara Gajkowska; Michael R Dashwood; Emerson T Fioretto; Karina M Gagliardo; Ana R De Lima; Antonio A C M Ribeiro
Journal:  J Mol Histol       Date:  2005-02       Impact factor: 2.611

2.  Endothelin-1 as a neuropeptide: neurotransmitter or neurovascular effects?

Authors:  Michael R Dashwood; Andrzej Loesch
Journal:  J Cell Commun Signal       Date:  2009-10-22       Impact factor: 5.782

Review 3.  Neuronal Nitric Oxide Synthase in Vascular Physiology and Diseases.

Authors:  Eduardo D Costa; Bruno A Rezende; Steyner F Cortes; Virginia S Lemos
Journal:  Front Physiol       Date:  2016-06-02       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.